SightfileU.S. market data from official filings

Companies › FBRX

FORTE BIOSCIENCES INC (FBRX)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001419041 · EDGAR filings · Updated 2026-07-28

FORTE BIOSCIENCES INC (FBRX) has reported institutional ownership of 97.4%, with 68 institutional managers holding positions valued at $350.2M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
97.4%
Institutional managers
68
Reported 13F value
$350.2M
Insider activity
17 trans.
$254.9K net buying
Data flags
2 active
from SEC filings

Filings this week (6)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, FORTE BIOSCIENCES INC has 68 institutional holders and institutional ownership of 97.4%.

Insider activity

Insiders reported 17 transactions (1 buys, 0 sells) across 2 reporting insiders, with a net reported value of $254.9K.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2024-11-14 (recurring since 2020-02-27) — source filing. The authoritative details are those stated in the filing itself.
Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2023-09-20 (recurring since 2023-09-20) — source filing. The authoritative details are those stated in the filing itself.

Related companies

ANTERIS TECHNOLOGIES GLOBAL (AVR) · REGENXBIO INC (RGNX) · SUTRO BIOPHARMA INC (STRO) · ATAIBECKLEY (ATAI) · NEUROPACE INC (NPCE) · ROCKET PHARMACEUTICALS I (RCKT)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-28.